IU Health Bloomington understands that clinical research is an important contributor to patient satisfaction and improved clinical outcomes. The hospital is committed to aggressively developing a robust research environment in order to better serve the surrounding community and improve access to care throughout the IU Health System.
Our commitment to developing and maintaining a collaborative research environment allows our physicians to explore a variety of treatment options and allows them to provide cutting-edge therapies to their patients. Below is a list of the clinical trials available for participation at IU Health Bloomington. Please contact the IU Health Bloomington research office 812.353.5494 for more information.
SCUSF-0806 PI-David Lee, MD
Phase II placebo-controlled trial of lisinopril and Coreg CR to reduce cardiotoxicity in patients with breast cancer receiving (neo) adjuvant chemotherapy with trastuzumab (Herceptin)
PROMIS PI-Benjamin Parsons, DO
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score (PROMIS)
CALBG 70807 PI-David Lee, MD
The Men’s Eating and Living (MEAL) Study: A Randomized Trial of Diet to Alter Disease Progression in Prostate Cancer Patients on Active Surveillance.
RTOG 0815 PI-David Lee, MD
A Phase III prospective randomized trial of dose-escalated radiotherapy with or without short-term androgen deprivation therapy for patients with intermediate-risk prostate cancer.
HOG MM12 PI-Benjamin Parsons, DO
A Phase 1/2, Multicenter, Single-arm, Nonrandomized, Open-label and Dose-escalation Study of Weekly Carfilzomib and Dexamethasone for Patients With Progressive Multiple Myeloma.
DSC127-2012 PI-Jodie Harper, MD
A Randomized, Double-Blind, Parallel-group, Vehicle and Standard of Care-controlled Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of DSC127 in Treating Non-healing Foot Ulcers in Subjects with Diabetes Mellitus
The Indiana Biobank
A collection of a blood sample and personal health information for use in future research studies